MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

A comprehensive characterisation of the salivary proteome of patients with Parkinson’s disease

J.M. Masters, A.J. Noyce, S. Lynham, T.T. Warner, G. Giovannoni, G.B. Proctor (Herts, United Kingdom)

Meeting: 2016 International Congress

Abstract Number: 732

Keywords: Sialorrhea

Session Information

Date: Tuesday, June 21, 2016

Session Title: Parkinson's disease: Pathophysiology

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To comprehensively characterise the salivary proteome of patients with Parkinson’s disease (PD) and generate potential biomarker candidates for future studies.

Background: Saliva may be an ideal fluid for biomarker discovery in PD, given non-invasive collection methods. LC-MS/MS mass spectrometry is a powerful tool for biomarker candidate generation as it can quantify large numbers of proteins across a large dynamic range and permits hypothesis-free, data driven analysis.

Methods: We performed label-free LC-MS/MS mass spectrometry to comprehensively characterise the proteome of three patients with PD and a single age matched control. Quantification of proteins was performed based on spectral count data using DESeq (Differential Expression Analysis for Sequence count data). Protein Set Enrichment Analysis (PSEA) was used to determine whether sets of proteins related to different gene ontology terms were upregulated in the patient vs control saliva.

Results: A total of 70730 spectra corresponding to 527 different proteins were identified across all samples. Label-free quantification with DESeq revealed 15 proteins to be significantly increased in abundance and 7 proteins to be significantly decreased in the patient samples versus control (see Table 1, Fig 1). S100-A9 and S100-A8 had the lowest and second lowest q values for upregulation in the patient samples and were approximately 4.7 and 8 times more abundant in the patient samples than the control, respectively. PSEA revealed that across the entire proteome, there was an upregulation of protein sets related to the inflammatory response in the patient saliva.

Conclusions: To our knowledge, this is the first time that saliva from patients with Parkinson’s disease has been analysed by mass spectrometry. Our data may be useful for informing further biomarker discovery studies; for example, the proteins identified as upregulated could be taken forward for analysis in more targeted mass-spectrometry experiments with a larger sample size. The finding of an upregulation of proteins related to the inflammatory response supports previous suggestions that patients with PD may have a greater degree of inflammation in the oral cavity than healthy controls.

To cite this abstract in AMA style:

J.M. Masters, A.J. Noyce, S. Lynham, T.T. Warner, G. Giovannoni, G.B. Proctor. A comprehensive characterisation of the salivary proteome of patients with Parkinson’s disease [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/a-comprehensive-characterisation-of-the-salivary-proteome-of-patients-with-parkinsons-disease/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/a-comprehensive-characterisation-of-the-salivary-proteome-of-patients-with-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley